SCHEMBL8312315

SCHEMBL8312315

Cc1ccc(-c2ccnc(Nc3ccc(C(=O)N4CCN(C[C@H](C)O)CC4)cc3)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 3/20 0.54
▸ CDK2 P24941 3/20 0.54
▸ JAK2 O60674 8/20 0.48
▸ JAK3 P52333 7/20 0.48
▸ IKBKB O14920 3/20 0.48
▸ CHUK O15111 3/20 0.48
▸ JAK1 P23458 2/20 0.48
▸ TYK2 P29597 2/20 0.48
▸ HDAC1 Q13547 2/20 0.48
▸ HDAC3 O15379 1/20 0.48
▸ NCOR1 O75376 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.48
▸ MTOR P42345 1/20 0.47
▸ SMG1 Q96Q15 1/20 0.47
▸ CAMK2D Q13557 4/20 0.46
▸ MKNK2 Q9HBH9 1/20 0.46
▸ IKBKG Q9Y6K9 1/20 0.46
▸ DYRK2 Q92630 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14021289 0.92 CDK1 (0.51) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL14021288 0.92 CDK1 (0.51) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL14021585 0.87 CDK1 (0.53) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL14021571 0.85 CDK1 (0.66) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL8205109 0.85 CDK2 (0.55) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL14021564 0.84 MTOR (0.60) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL14021582 0.84 GAA (0.58) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL14021606 0.83 IKBKB (0.53) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL14021591 0.83 CDK2 (0.53) CDK1CDK2JAK2JAK3IKBKB
SCHEMBL14021578 0.82 JAK2 (0.64) CDK2JAK2JAK3JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 — — WO disclosed
Send feedback